Categories: Business News

LANXESS Business Unit Advanced Industrial Intermediates Gains New Strengths/ Sets New Direction

Mumbai, Jan 13, 2015: LANXESS, the global specialty chemicals company is currently undergoing strategic realignment within the organization as part of its ‘Let’s LANXESS Again’ project. One of its largest business units Advanced Industrial Intermediates (AII), which until now catered to intermediates for agrochemicals, pharmaceuticals, dyes, coatings among others, will now also take over the antioxidants and accelerators businesses previously managed by the Rubber Chemicals (RUC) business unit at LANXESS.

The restructured business unit AII’s core business will continue to be the production and global marketing of high-grade industrial chemicals. The expansion of its current product portfolio through the addition of the business unitRUC’s antioxidants and accelerators fits in very well with the existing business model. This realignment will allow leveraging the synergies between the two erstwhile BUs, build a competitive sales structure with improved efficiencies, allow competitive access to raw materials and utilities, enable sharing of resources and optimizing costs. With its networkedglobal production organization and marketing operations, the AII business unit has been highly successful in the past, even though its products are in an environment of stiff competition from the products of other suppliers.

“In the AII business unit we operate a chemical business that has long-term perspectives. This is based largely on sustainable customer relations and trust built up over many years in the markets in question. Similarly, we want to develop strong relations with the customers of antioxidants and accelerators previously served by BU RUC. It is very important to me that we maintain long-term customer relationships in the future as well. We would continue to leverage these relationships and our market experiences for reaching out to customers with the rubber chemicals products” said Mr. Hubert Fink, Head – Business Unit, Advanced Industrial Intermediates, LANXESS AG.

“I believe that we have an excellent example of efficient, competitive and sustainable manufacturing with the BU AII’s manufacturing operations in Nagda, Madhya Pradesh. Under the realm of BU AII, the RUC production assets in Jhagadia will also be run in a similar manner. Thus, we now have a wider basket of products to offer to our customers in India and overseas. Together with these assets, an expanded portfolio and our capabilities, I am optimistic that we will be able to leverage the synergies for profitable growth”, added Mr. Neelanjan Banerjee, Senior Vice President – BU AII and Senior Executive Director, LANXESS India.CCI Newswire

The Pharma Times News Bureau

Recent Posts

SOULFLOWER LAUNCHES INDIA’S 1ST CLINICALLY PROVEN ROSEMARY REDENSYL HAIR GROWTH SERUM (TETRAGAIN™)

Breakthrough Formulation Helps Reduce Hair Fall By 64.89%, Enhance Hair Growth & Address Premature Greying…

15 hours ago

Neuberg Diagnostics secures INR 940 crores from Kotak Alt in the largest-ever primary fund-raise in the Indian diagnostics sector

New Delhi, January 15, 2025: Neuberg Diagnostics, founded in 2017 and headquartered in Chennai, has rapidly…

15 hours ago

World’s First Robotic Cardiac Telesurgeries Performed Over a Distance of 286 Km Using Made-in-India Surgical Robotic System, SSI Mantra

·         The Telerobotic-assisted Internal Mammary Artery Harvesting procedure was successfully completed in 58 minutes, with exceptional precision and…

3 days ago

DFE Pharma expands its C2F Center of Excellence to advance the development of critical respiratory treatments

This expansion enables DFE Pharma to offer specialized analytical services for Dry Powder Inhalation (DPI)…

3 days ago

A Growing Threat: Navigating HMPV and Emerging Respiratory Illnesses in Children

Dr. Sujatha Thyagarajan, Lead & HOD - Pediatric Intensive Care and Pediatric Emergency at Aster…

3 days ago

Software Engineer from Malaysia undergoes Robotic Direct Anterior Hip Replacement Surgery at Fortis Hospital Bannerghatta Road

Bangalore, January 13, 2025: Fortis Hospital Bannerghatta Road, has successfully treated a 53-year-old software engineer from…

3 days ago